Lenalidomide as first-line therapy for elderly CLL patients.
Judith A
JA
Gilbert
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D000077269:Lenalidomide; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D013792:Thalidomide; D000077269:Lenalidomide